Studies also show that downregulating CPT1 with etomoxir has a positive outcome on obesity and glucose metabolism92,93, Our study confirms that P479L mutant mice were resistant to rotenone-induced PD-mimicking disease, in part through a shift toward the metabolism of glucose over lipids. Here, CPT1A is linked to obesity disorder.